Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Creative Testing Solutions (CTS) is the largest nonprofit blood donor testing organization in the United States, responsible for screening approximately 75% of the nation's blood supply. Established as a joint venture between the American Red Cross, Vitalant, and OneBlood, the company operates high-volume laboratories that perform critical infectious disease testing on millions of blood donations annually. Their service portfolio includes nucleic acid testing (NAT) and serological assays to detect pathogens such as HIV, Hepatitis B and C, West Nile Virus, and Zika. CTS plays a vital role in public health by ensuring the safety and availability of blood products for transfusion and medical use.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Creative Testing Solutions.